| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | RVI BIOTECNOLOGÍA | 82,12% | 98,94% | 59,86% | 138,11% |
| AB SICAV I-CHINA NET ZERO SOLUTIONS PORTFOLIO A EUR H | RVI CHINA | 82,09% | 67,96% | · | · |
| BGF NEXT GENERATION TECHNOLOGY A4 EUR | RVI TECNOLOGÍA | 82,09% | 131,50% | · | · |
| BGF NEXT GENERATION TECHNOLOGY A2 EUR | RVI TECNOLOGÍA | 82,06% | 131,77% | · | · |
| BGF NEXT GENERATION TECHNOLOGY A2 SEK | RVI TECNOLOGÍA | 82,06% | 131,21% | 42,19% | · |
| WELLINGTON ASIA TECHNOLOGY FUND S USD ACC | RVI TECNOLOGÍA | 82,02% | 146,67% | 110,07% | · |
| PICTET - BIOTECH R USD | RVI BIOTECNOLOGÍA | 81,88% | 80,07% | 53,73% | 146,16% |
| T.ROWE CHINA EVOLUTION EQUITY FUND AN (CNH) | RVI CHINA | 81,88% | 81,26% | · | · |
| BGF NEXT GENERATION TECHNOLOGY A2 USD | RVI TECNOLOGÍA | 81,78% | 133,27% | 42,26% | · |
| BGF NEXT GENERATION TECHNOLOGY A4 USD | RVI TECNOLOGÍA | 81,73% | 133,37% | · | · |
